PAR
Click for more information
12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worse Case, page-31

  1. Gan_Gans
    2,121 Posts.
    lightbulb Created with Sketch. 568
    clock Created with Sketch.
    10/02/22
    14:39
    Post #: 59487010
    True - but the guidance is for acute not chronic pain and also, its up to Paradigm a bit - why the hell haven't they applied for a FastTrack designation is beyond me. Yes, it comes into play at NDA time, but would do a lot for investor confidence.
    PAR Price at posting: $1.43 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢ 		Change
0.035(12.7%) 		Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.